Perpetual Ltd’s Quest Diagnostics DGX Stock Holding History

Perpetual Ltd’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-14,164	Closed	-$820K	–	221
2014 Q1	$820K	Buy	+14,164	New	+$759K	0.12%	129

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perpetual Ltd's DGX Position: Q2 2014 in Review

Perpetual Ltd sold out of Quest Diagnostics (DGX) in Q2 2014, closing a stake of 14,164 shares — an estimated $820K sold.

Perpetual Ltd first reported a position in DGX in Q1 2014 and held it in 1 quarter. The position peaked at $820K in Q1 2014. 496 funds tracked by Wall St. Rank hold DGX as of Q2 2014.

Perpetual Ltd reported no remaining Quest Diagnostics position as of Q2 2014 after selling out during the quarter.
Perpetual Ltd sold 14,164 Quest Diagnostics shares in Q2 2014, an estimated $820K.
Perpetual Ltd first reported a position in Quest Diagnostics in Q1 2014 and held it in 1 quarter.
Perpetual Ltd's Quest Diagnostics position peaked at $820K in Q1 2014.
496 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2014.

Based on Perpetual Ltd's 13F filing for Q2 2014, filed 26 Sep 2017.